{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:43:33Z","timestamp":1782225813743,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.mcna.2004.06.002","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:11Z","timestamp":1113821591000},"page":"1257-1271","source":"Crossref","is-referenced-by-count":91,"title":["Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure"],"prefix":"10.1016","volume":"88","author":[{"suffix":"Jr.","given":"Joseph L.","family":"Izzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Gradman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2004.06.002_bib1","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 Express","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.06.002_bib2","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib3","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1161\/hc4901.102568","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic HF in the adult: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"104","author":"Hunt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib4","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","article-title":"Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988\u20131991","volume":"25","author":"Burt","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. the Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-9149(99)00243-X","article-title":"Insulin resistance syndrome and left ventricular mass in an elderly population (the Rotterdam Study)","volume":"84","author":"Rheeder","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mcna.2004.06.002_bib8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM199904223401601","article-title":"Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989","volume":"340","author":"Mosterd","year":"1999","journal-title":"N Engl J Med"},{"issue":"1 Pt 2","key":"10.1016\/j.mcna.2004.06.002_bib9","first-page":"I26","article-title":"The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study","volume":"75","author":"Savage","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib10","series-title":"Hypertension primer","first-page":"175","article-title":"Pathogenesis of hypertensive left ventricular hypertrophy and diastolic dysfunction","author":"Frohlich","year":"2003"},{"key":"10.1016\/j.mcna.2004.06.002_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.jhh.1001523","article-title":"The determinants of left ventricular hypertrophy defined by Sokolow-Lyon criteria in untreated hypertensive patients","volume":"17","author":"Antikainen","year":"2003","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1016\/j.mcna.2004.06.002_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1524-6175.2003.01246.x","article-title":"High prevalence of target organ damage in young, African American inner-city men with hypertension","volume":"5","author":"Post","year":"2003","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.mcna.2004.06.002_bib13","series-title":"Hypertension primer","first-page":"235","article-title":"Cardiovascular risk factors and hypertension","author":"Kannel","year":"2003"},{"key":"10.1016\/j.mcna.2004.06.002_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","article-title":"Prognostic significance of left ventricular hypertrophy","volume":"141","author":"Vakili","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2004.06.002_bib15","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1532-5415.1998.tb04546.x","article-title":"Association of electrocardiographic left ventricular hypertrophy with the incidence of new congestive heart failure","volume":"46","author":"Aronow","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.mcna.2004.06.002_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-110-2-101","article-title":"Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study","volume":"110","author":"Levy","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib18","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0735-1097(95)00381-9","article-title":"Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective","volume":"26","author":"Vasan","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2004.06.002_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","article-title":"Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study","volume":"138","author":"Haider","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/003655102764654303","article-title":"Ambulatory blood pressure and left ventricular mass in older age","volume":"62","author":"Wendelin-Saarenhovi","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.mcna.2004.06.002_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1161\/01.CIR.95.6.1464","article-title":"Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation","volume":"95","author":"Mancia","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00004872-200202000-00024","article-title":"Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study","volume":"20","author":"de Simone","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.mcna.2004.06.002_bib23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/00004872-200304000-00022","article-title":"Pulse pressure\/stroke index and left ventricular geometry and function: the LIFE Study","volume":"21","author":"Palmieri","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.mcna.2004.06.002_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.HYP.36.4.489","article-title":"Impact of arterial stiffening on left ventricular structure","volume":"36","author":"Roman","year":"2000","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2004.06.002_bib25","first-page":"B35","article-title":"Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The Study Investigators","volume":"23","author":"Gerstein","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2004.06.002_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1365-2796.2003.01155.x","article-title":"Blood pressure independent association of microalbuminuria and left ventricular hypertrophy in hypertensive men","volume":"254","author":"Dell'omo","year":"2003","journal-title":"J Int Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.HYP.0000114696.96318.4e","article-title":"Cardiovascular risk factors and sequelae in hypertensive children identified by referral versus school-based screening","volume":"43","author":"Sorof","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib28","first-page":"581","article-title":"Relation between age, left ventricular mass and ventricular arrhythmias in patients with hypertension","volume":"9","author":"Ferrara","year":"1995","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.mcna.2004.06.002_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2143\/AC.58.4.2005287","article-title":"Relation between stage of left ventricular diastolic dysfunction and QT dispersion","volume":"58","author":"Gunduz","year":"2003","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.mcna.2004.06.002_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ajh\/2.2.128","article-title":"Left ventricular hypertrophy as a factor in arrhythmias and sudden death","volume":"2","author":"McLenachan","year":"1989","journal-title":"Am J Hypertens"},{"issue":"6 Pt 2 Suppl","key":"10.1016\/j.mcna.2004.06.002_bib31","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/S0002-8703(98)70251-0","article-title":"Clinical definition and epidemiology of advanced heart failure","volume":"135","author":"Adams","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2004.06.002_bib32","series-title":"Hypertension primer","first-page":"460","article-title":"Management of hypertensive patients with left ventricular hypertrophy and diastolic dysfunction","author":"Devereux","year":"2003"},{"key":"10.1016\/j.mcna.2004.06.002_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib34","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.mcna.2004.06.002_bib35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib37","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/01.CIR.0000093435.04334.1F","article-title":"Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship","volume":"108","author":"Mitchell","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib38","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0002-8703(76)80156-1","article-title":"Norepinephrine\u2014the myocardial hypertrophy hormone","volume":"91","author":"Laks","year":"1976","journal-title":"Am Heart J"},{"issue":"Suppl 2","key":"10.1016\/j.mcna.2004.06.002_bib39","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00005344-199600002-00008","article-title":"Cardiovascular hypertrophy: role of angiotensin II and bradykinin","volume":"27","author":"Waeber","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mcna.2004.06.002_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/978-1-4615-5385-4_21","article-title":"Comparison of therapeutic studies on regression of left ventricular hypertrophy","volume":"432","author":"Schmieder","year":"1997","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2004.06.002_bib42","first-page":"3","article-title":"Cardiac remodeling by fibrous tissue: role of local factors and circulating hormones","volume":"30","author":"Sun","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/07853899708999357","article-title":"Metabolic responses of extracellular matrix in tissue repair","volume":"29","author":"Weber","year":"1997","journal-title":"Ann Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib44","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0895-7061(01)02200-2","article-title":"Sibling correlation of left ventricular mass and geometry in hypertensive African-Americans and whites: the HyperGEN study. Hypertension Genetic Epidemiology Network","volume":"14","author":"Arnett","year":"2001","journal-title":"Am J Hypertens"},{"issue":"Suppl 5","key":"10.1016\/j.mcna.2004.06.002_bib45","first-page":"S76","article-title":"Parental left ventricular hypertrophy predicts Doppler-derived diastolic filling in young offspring of hypertensive subjects","volume":"11","author":"Galderisi","year":"1993","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.mcna.2004.06.002_bib46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/hy1001.092650","article-title":"Linkage of left ventricular contractility to chromosome 11 in humans: the HyperGEN Study","volume":"38","author":"Arnett","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib47","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.06.002_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199909023411012","article-title":"Apoptosis and heart failure","volume":"341","author":"Williams","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib49","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0002-9149(02)02838-2","article-title":"Relation of aortic distensibility determined by magnetic resonance imaging in patients>or=60 years of age to systolic heart failure and exercise capacity","volume":"90","author":"Rerkpattanapipat","year":"2002","journal-title":"Am J Cardiol"},{"issue":"3 Pt 2","key":"10.1016\/j.mcna.2004.06.002_bib50","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.HYP.38.3.588","article-title":"Cardioreparation in hypertensive heart disease","volume":"38","author":"Weber","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jama.281.7.634","article-title":"Increased pulse pressure and risk of heart failure in the elderly","volume":"281","author":"Chae","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.06.002_bib52","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/hy1201.098298","article-title":"Pulsatile hemodynamics in congestive heart failure","volume":"38","author":"Mitchell","year":"2001","journal-title":"Hypertension"},{"issue":"2 Part 2","key":"10.1016\/j.mcna.2004.06.002_bib53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.HYP.37.2.346","article-title":"Left ventricle and arteries: structure, function, hormones, and disease","volume":"37","author":"Cohn","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4615-5385-4_27","article-title":"Hypertension, left ventricular hypertrophy, and coronary flow reserve","volume":"432","author":"Frohlich","year":"1997","journal-title":"Adv Exp Med Biol"},{"issue":"4 Pt 1","key":"10.1016\/j.mcna.2004.06.002_bib55","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.88.4.1456","article-title":"Effects of age and aerobic capacity on arterial stiffness in healthy adults","volume":"88","author":"Vaitkevicius","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib56","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.jhh.1000899","article-title":"Overview of the outcome trials in older patients with isolated systolic hypertension","volume":"13","author":"Staessen","year":"1999","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.mcna.2004.06.002_bib57","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(00)03306-7","article-title":"Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials","volume":"356","author":"Pahor","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib58","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","author":"The ALLHAT Officers","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2004.06.002_bib59","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/hc3901.096700","article-title":"Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril","volume":"104","author":"Mathew","year":"2001","journal-title":"Circulation"},{"issue":"11 Pt 1","key":"10.1016\/j.mcna.2004.06.002_bib60","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0895-7061(03)01018-5","article-title":"Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis","volume":"16","author":"Verdecchia","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.mcna.2004.06.002_bib61","first-page":"5","article-title":"Mechanical and other factors relating to left ventricular hypertrophy","volume":"1","author":"Fagard","year":"1994","journal-title":"Blood Press Suppl"},{"key":"10.1016\/j.mcna.2004.06.002_bib62","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0140-6736(01)07186-0","article-title":"Blood-pressure reduction and cardiovascular risk in HOPE study","volume":"358","author":"Sleight","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib63","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1161\/hy1101.099502","article-title":"Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy","volume":"38","author":"Svensson","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2004.06.002_bib64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.CIR.0000083724.28630.C3","article-title":"Losartan Intervention for Endpoint Reduction in Hypertension Study I. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study","volume":"108","author":"Okin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2004.06.002_bib65","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2004.06.002_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-139-3-200308050-00006","article-title":"Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial","volume":"139","author":"Devereux","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib67","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib68","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction","volume":"327","author":"Studies of Left Ventricular Dysfunction (SOLVD) Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib69","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan in Acute Myocardial Infarction Trial I. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2004.06.002_bib70","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.265.24.3255","article-title":"Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"JAMA"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712504000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712504000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T16:46:11Z","timestamp":1550076371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712504000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0025712504000732"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2004.06.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}